Cysteine supplementation to cysteine-free intravenous feeding regimens in newborn infants.
To determine if cysteine is an essential amino acid for the intravenously fed newborn infant, growth parameters, nitrogen balance, plasma sulfur amino acid levels, and urinary amino acid excretion of premature and term infants were measured in the presence or absence of infused cysteine. Control intravenous formulations provided amino acids, including adequate methionine, carbohydrate, lipid, minerals, vitamins, and trace elements to all infants. Group and pair-matched comparisons showed that nitrogen retention, weight change, and growth in length and head circumference were not affected by cysteine supplementation of 77 mg/kg/24 h. The failure of cysteine supplementation to alter nitrogen retention was independent of postnatal age or gestational age. Plasma 1/2 cystine concentration was increased by 60% in the supplemented group with a concomitant 3-fold increase in urinary excretion of 1/2 cystine and taurine, but not of urinary methionine or cystathionine. Cysteine-supplemented infants exhibited a small increase in 3-methylhistidine excretion compared to pair-matched controls, suggesting that either an increase in muscle protein catabolism or an increase in muscle mass may have occurred.
D000596:Amino Acids / Q000378:metabolism; D000601:Amino Acids, Essential; D003545:Cysteine; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D009584:Nitrogen / Q000378:metabolism; D010288:Parenteral Nutrition; D010289:Parenteral Nutrition, Total
D000596:Amino Acids; D000601:Amino Acids, Essential; D003545:Cysteine; D009584:Nitrogen